Thymosin α1: a single drug with multiple targets in cystic fibrosis.

Plain Language Summary

This paper highlights the potential of thymosin alpha-1 as a multi-target treatment for cystic fibrosis, a genetic disease caused by defective chloride channels. The peptide's ability to address multiple disease mechanisms simultaneously makes it a uniquely promising single-drug approach for this complex condition.